Acadia Pharma (ACAD) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $29.21 +2.67%
Financial Fact:
Net loss per common share, basic and diluted: -0.61
Today's EPS Names:
BMNM, KG, NHC, More
Financial Fact:
Net loss per common share, basic and diluted: -0.61
Today's EPS Names:
BMNM, KG, NHC, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q3 EPS of ($0.39), $0.01 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acadia Pharmaceuticals (ACAD) PT Raised to $37 at RBC Capital on 'Strong Sales'
- Minerva Neurosciences (NERV) Tops Q2 EPS by 5c
- Acadia Pharmaceuticals (ACAD) PT Raised to $36 at Citizens: Remains a Top Pick
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
